The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2

Nature Immunology

Volumn 15, Issue 9, 2014, Pages 866-874

  Yi, Zuoan ^a   Lin, Wai Wai ^a   Stunz, Laura L ^a   Bishop, Gail A ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; JANUS KINASE 1; JANUS KINASE 3; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; THYMUS;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2; JANUS KINASE 1; JANUS KINASE 3; MICE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TNF RECEPTOR-ASSOCIATED FACTOR 3;

EID: 84906310292     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2944     Document Type: Article

References (49)

1. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008).
2. Burchill, M.A. et al. Linked TCR and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28, 112-121 (2008).
3. Lio, C.W. & Hsieh, C.S. A two-step process for thymic regulatory T cell development. Immunity 28, 100-111 (2008).
4. Malek, T.R. The biology of IL-2. Annu. Rev. Immunol. 26, 453-479 (2008).
5. Johnston, J.A., Bacon, C.M., Riedy, M.C. & O'Shea, J.J. Signaling by IL-2 and related cytokines: Jaks, STATs, and relationship to immunodeficiency. J. Leukoc. Biol. 60, 441-452 (1996).
6. Minami, Y. & Taniguchi, T. IL-2 signaling: recruitment and activation of multiple protein tyrosine kinases by the components of the IL-2 receptor. Curr. Opin. Cell Biol. 7, 156-162 (1995).
7. Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. & Farrar, M.A. IL-2Rβ dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280-290 (2007).
8. Yao, Z. et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood. 109, 4368-4375 (2007).
9. Burns, L.A., Karnitz, L.M., Sutor, S.L. & Abraham, R.T. IL-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. J. Biol. Chem. 268, 17659-17661 (1993).
10. Zhou, Y.J. et al. Hierarchy of protein tyrosine kinases in IL-2 signaling: activation of Syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation. Mol. Cell. Biol. 20, 4371-4380 (2000).
11. Sporri, B., Kovanen, P.E., Sasaki, A., Yoshimura, A. & Leonard, W.J. JAB/SOCS1/SSI-1 is an IL-2-induced inhibitor of IL-2 signaling. Blood 97, 221-226 (2001).
12. Yu, C.R. et al. SOCS3 regulates proliferation and activation of T-helper cells. J. Biol. Chem. 278, 29752-29759 (2003).
13. Migone, T.S. et al. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the IL-2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc. Natl. Acad. Sci. USA 95, 3845-3850 (1998).
14. Simoncic, P.D., Lee-Loy, A., Barber, D.L., Tremblay, M.L. & McGlade, C.J. The T cell protein tyrosine phosphatase is a negative regulator of Jaks 1 and 3. Curr. Biol. 12, 446-453 (2002).
15. Ibarra-Sánchez, M.J. et al. The T-cell protein tyrosine phosphatase. Semin. Immunol. 12, 379-386 (2000).
16. You-Ten, K.E. et al. Impaired bone marrow microenvironment and immune function in TCPTP-deficient mice. J. Exp. Med. 186, 683-693 (1997).
17. Wiede, F. et al. TCPTP attenuates T cell signaling to maintain tolerance in mice. J. Clin. Invest. 121, 4758-4774 (2011).
18. Häcker, H. et al. Specificity in TLR signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006).
19. Hildebrand, J.M. et al. Roles of TRAF3 and TRAF5 in immune cell functions. Immunol. Rev. 244, 55-74 (2011).
20. Yi, Z., Lin, W.W., Stunz, L.L. & Bishop, G.A. Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions. Cytokine Growth Factor Rev. 25, 147-156 (2014).
21. Bishop, G.A. The many faces of TRAF molecules in immune regulation. J. Immunol. 191, 3483-3485 (2013).
22. Xie, P., Kraus, Z.J., Stunz, L.L., Liu, Y. & Bishop, G.A. TRAF3 is required for T cell-mediated immunity and TCR/CD28 signaling. J. Immunol. 186, 143-155 (2011).
23. Yi, Z., Stunz, L.L. & Bishop, G.A. TRAF3 plays a key role in development and function of invariant natural killer T cells. J. Exp. Med. 210, 1079-1086 (2013).
24. Chang, J.H. et al. TRAF3 regulates the effector function of regulatory T cells and humoral immune responses. J. Exp. Med. 211, 137-151 (2014).
25. Bailey-Bucktrout, S.L. & Bluestone, J.A. Regulatory T cells: stability revisited. Trends Immunol. 32, 301-306 (2011).
26. Josefowicz, S.Z. & Rudensky, A. Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616-625 (2009).
27. Floess, S. et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38 (2007).
28. Thornton, A.M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441 (2010).
29. Yadav, M. et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713-1722 (2012).
30. Weiss, J.M. et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209, 1723-1742 (2012).
31. Hofmann, J., Mair, F., Greter, M., Schmidt-Supprian, M. & Becher, B. NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses. J. Exp. Med. 208, 1917-1929 (2011).
32. Murray, S.E. Cell-intrinsic role for NIK in peripheral maintenance but not thymic development of Foxp3+ regulatory T cells in mice. PLoS ONE 8, e76216 (2013).
33. Moran, A.E. et al. TCR signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279-1289 (2011).
34. Lal, G. & Bromberg, J.S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 114, 3727-3735 (2009).
35. Sakaguchi, S., Fukuma, K., Kuribayashi, K. & Masuda, T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72-87 (1985).
36. Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632 (2007).
37. Bautista, J.L. et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10, 610-617 (2009).
38. Yu, A., Zhu, L., Altman, N.H. & Malek, T.R. A low IL-2R signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30, 204-217 (2009).
39. Bensinger, S.J. et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172, 5287-5296 (2004).
40. Walsh, P.T. et al. PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs. J. Clin. Invest. 116, 2521-2531 (2006).
41. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940 (2007).
42. Motegi, H., Shimo, Y., Akiyama, T. & Inoue, J. TRAF6 negatively regulates the Jak1-Erk pathway in IL-2 signaling. Genes Cells 16, 179-189 (2011).
43. van Vliet, C. et al. Selective regulation of TNF-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat. Immunol. 6, 253-260 (2005).
44. Lin, W.W., Hildebrand, J.M. & Bishop, G.A. A complex relationship between TRAF3 and non-canonical NF-κB2 activation in B lymphocytes. Front Immunol. 4, 477 (2013).
45. He, J.Q., Saha, S.K., Kang, J.R., Zarnegar, B. & Cheng, G. Specificity of TRAF3 in its negative regulation of the non-canonical NF-κB pathway. J. Biol. Chem. 282, 3688-3694 (2007).
46. Xie, P., Stunz, L.L., Larison, K.D., Yang, B. & Bishop, G.A. TRAF3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27, 253-267 (2007).
47. Holst, J. et al. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1, 406-417 (2006).
48. Ostanin, D.V. et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G135-G146 (2009).
49. Tiganis, T., Bennett, A.M., Ravichandran, K.S. & Tonks, N.K. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol. Cell. Biol. 18, 1622-1634 (1998).